Mixed micelles of TPGS and Soluplus^® for co-delivery of paclitaxel and fenretinide: in vitro and in vivo anticancer study

References

• Bernabeu E, Gonzalez L, Cagel M, Gergic EP, Moretton MA, Chiappetta DA. 2016. Novel Soluplus((R))-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines. Colloids Surf B Biointerfaces. 140:403–411.
   PubMed Web of Science ®Google Scholar
• Bernabeu E, Helguera G, Legaspi MJ, Gonzalez L, Hocht C, Taira C, Chiappetta DA. 2014. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane(R). Colloids Surf B Biointerfaces. 113:43–50.
   PubMed Web of Science ®Google Scholar
• Chen NE, Maldonado NV, Khankaldyyan V, Shimada H, Song MM, Maurer BJ, Reynolds CP. 2016. Reactive oxygen species mediates the synergistic activity of fenretinide combined with the microtubule inhibitor ABT-751 against multidrug-resistant recurrent neuroblastoma xenografts. Mol Cancer Ther. 15(11):2653–2664.
   PubMed Web of Science ®Google Scholar
• Cho H, Lai TC, Tomoda K, Kwon GS. 2015. Polymeric micelles for multi-drug delivery in cancer. AAPS PharmSciTech. 16(1):10–20.
   PubMed Web of Science ®Google Scholar
• Dhanikula AB, Singh DR, Panchagnula R. 2005. In vivo pharmacokinetic and tissue distribution studies in mice of alternative formulations for local and systemic delivery of Paclitaxel: gel, film, prodrug, liposomes and micelles. Curr Drug Deliv. 2(1):35–44.
   PubMedGoogle Scholar
• Dilley RL, Verma P, Cho NW, Winters HD, Wondisford AR, Greenberg RA. 2016. Break-induced telomere synthesis underlies alternative telomere maintenance. Nature. 539(7627):54–58.
   PubMed Web of Science ®Google Scholar
• Ding Y, Wang C, Wang Y, Xu Y, Zhao J, Gao M, Ding Y, Peng J, Li L. 2018. Development and evaluation of a novel drug delivery: Soluplus((R))/TPGS mixed micelles loaded with piperine in vitro and in vivo. Drug Dev Ind Pharm. 44(9):1409–1416.
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. 2011. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 63(3):136–151.
   PubMed Web of Science ®Google Scholar
• Hail N Jr, Kim HJ, Lotan R. 2006. Mechanisms of fenretinide-induced apoptosis. Apoptosis. 11(10):1677–1694.
   PubMed Web of Science ®Google Scholar
• Hu M, Zhang J, Ding R, Fu Y, Gong T, Zhang Z. 2017. Improved oral bioavailability and therapeutic efficacy of dabigatran etexilate via Soluplus-TPGS binary mixed micelles system. Drug Dev Ind Pharm. 43(4):687–697.
   PubMed Web of Science ®Google Scholar
• Janardhanan R, Butler JT, Banik NL, Ray SK. 2009. N-(4-Hydroxyphenyl) retinamide potentiated paclitaxel for cell cycle arrest and apoptosis in glioblastoma C6 and RG2 cells. Brain Res. 1268:142–153.
   PubMed Web of Science ®Google Scholar
• Jin X, Zhou B, Xue L, San W. 2015. Soluplus((R)) micelles as a potential drug delivery system for reversal of resistant tumor. Biomed Pharmacother. 69:388–395.
   PubMed Web of Science ®Google Scholar
• Kang MH, Wan Z, Kang YH, Sposto R, Reynolds CP. 2008. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation. J Natl Cancer Inst. 100(8):580–595.
   PubMedGoogle Scholar
• Li N, Zhao L, Qi L, Li Z, Luan Y. 2016. Polymer assembly: Promising carriers as co-delivery systems for cancer therapy. Prog Polym Sci. 58:1–26.
   Web of Science ®Google Scholar
• Liu J, Li J, Zhang JF, Xin XY. 2013. Combination of fenretinide and selenite inhibits proliferation and induces apoptosis in ovarian cancer cells. Int J Mol Sci. 14(11):21790–21804.
   PubMed Web of Science ®Google Scholar
• Malone W, Perloff M, Crowell J, Sigman C, Higley H. 2003. Fenretinide: a prototype cancer prevention drug. Expert Opin Investig Drugs. 12(11):1829–1842.
   PubMed Web of Science ®Google Scholar
• Neophytou CM, Constantinou C, Papageorgis P, Constantinou AI. 2014. D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces cell cycle arrest and apoptosis selectively in Survivin-overexpressing breast cancer cells. Biochem Pharmacol. 89(1):31–42.
   PubMed Web of Science ®Google Scholar
• Nigro A, Montico B, Casolaro V, Dal Col J. 2019. A novel dendritic cell-based vaccination protocol to stimulate immunosurveillance of aggressive cancers. Methods Mol Biol. 1884:317–333.
   PubMedGoogle Scholar
• Pratt MA, Niu M, White D. 2003. Differential regulation of protein expression, growth and apoptosis by natural and synthetic retinoids. J Cell Biochem. 90(4):692–708.
   PubMed Web of Science ®Google Scholar
• Sun Y, Yu B, Wang G, Wu Y, Zhang X, Chen Y, Tang S, Yuan Y, Lee RJ, Teng L, et al. 2014. Enhanced antitumor efficacy of vitamin E TPGS-emulsified PLGA nanoparticles for delivery of paclitaxel. Colloids Surf B Biointerfaces. 123:716–723.
   PubMed Web of Science ®Google Scholar
• Surapaneni MS, Das SK, Das NG. 2012. Designing paclitaxel drug delivery systems aimed at improved patient outcomes: current status and challenges. ISRN Pharmacol. 2012:1–15.
   Google Scholar
• Torchilin V. 2011. Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev. 63(3):131–135.
   PubMed Web of Science ®Google Scholar
• Varma MV, Panchagnula R. 2005. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci. 25(4-5):445–453.
   PubMed Web of Science ®Google Scholar
• Wei Z, Hao J, Yuan S, Li Y, Juan W, Sha X, Fang X. 2009. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm. 376(1-2):176–185.
   PubMed Web of Science ®Google Scholar
• Wu GS, Lu JJ, Guo JJ, Huang MQ, Gan L, Chen XP, Wang YT. 2013. Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells. Pharmacol Rep. 65(2):453–459.
   PubMed Web of Science ®Google Scholar
• Yang H, Zhan Q, Wan YJ. 2011. Enrichment of Nur77 mediated by retinoic acid receptor beta leads to apoptosis of human hepatocellular carcinoma cells induced by fenretinide and histone deacetylase inhibitors. Hepatology. 53(3):865–874.
   PubMed Web of Science ®Google Scholar
• Zhao J, Xu Y, Wang C, Ding Y, Chen M, Wang Y, Peng J, Li L, Lv L. 2017. Soluplus/TPGS mixed micelles for dioscin delivery in cancer therapy. Drug Dev Ind Pharm. 43(7):1197–1204.
   PubMed Web of Science ®Google Scholar